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Abstract 
Background and Aim: Viral infections in the intensive care units (ICUs) often involve the central nervous 
system or respiratory tract. These infections can cause significant morbidity and mortality. Science the fact that 
there is effective treatment against some viruses, knowing the viruses that cause infections in ICU can be a 
great help in managing these patients. Hence, the study reviewed the major viruses in the ICU.  
Materials and Methods: We searched published articles on trends of viral infections in the intensive care 
units (ICUs). The articles were retrieved from databases of PubMed, Scopus, Google Scholar, and 
MEDLINE. 
Conclusion: Due to the significant outbreak of viruses in the ICU and the presence of effective treatments 
against some viruses, knowing the important viruses in this area and rapid diagnosing and treatment can be 
important. 
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Viruses are small structures which known as 
obligatory intracellular parasites, therefore they need 
host-cell machinery to replicate their DNA or RNA 
genome
1
. Viral diseases may be cause of significant 
morbidity and mortality. Patients with severe viral 
infections are often hospitalized in intensive care 
units (ICUs); on the other hand recent studies have 




ICU-acquired infections were defined as those 
acquired no less than 48 h after ICU admission. 
Patients hospitalized in ICUs are 5 to 10 times more 
likely to acquire nosocomial infections than other 
hospital patients
3
. Viral infections in the ICU often 
involve the respiratory or the central nervous system 
and can cause significant morbidity and mortality 
especially in immunocompromised patients. Different 
types of viruses in ICU include Orthomyxoviridae, 
Paramyxoviridae (RNA viruses). Adenoviridae, 
Herpesviridae (DNA viruses)
2
. In addition, bacterial 
and viral co-infections may be a risk factor for ICU 
admission, severity of disease, and mortality. Like 
pneumonia that derived from both viral and bacterial 
agents
4
. Therefore in this study we survey the 
importance of viruses in ICU infections. 
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Materials and Methods 
The databases of PubMed, Scopus, Google 
Scholar, and MEDLINE were searched for 
published articles on trends of viral infections 
in the intensive care units (ICUs).  
Human rhinoviruses (HRV) 
Human rhinoviruses (HRV) belongs to the 
Picornaviridae that is a family of small, icosahedral 
viruses with single-stranded, highly diverse positive 
strand RNA genomes. This viruses are responsible 
for more than one-half of cold-like illnesses
5
. HRV is 
divided into 3 distinct species: HRV species A, B, 
and C
6
. HRV is one of the most important viral 
agents that cause acute respiratory tract infections 
and has been detected in upper and lower respiratory 
tract
7
. HRV infections occur during all four seasons 
and were more common in spring and autumn. 
respiratory syncytial virus predominated from 
November to February
8
. RSV and HRV were the 
viruses identified most frequently in mixed infections 
in infants hospitalized with bronchiolitis
9
. HRV 
species C is associated with respiratory  tract 
infections, severe asthma exacerbations in children, 




In 2011, Reid et al studied the prevalence of human 
rhinovirus species C infection in a neonatal intensive 
care unit in the state of Tasmania, Australia. During 
this study, all infants in NPICU and SCN underwent 
screening for HRV using nasopharyngeal swabs. 
From 21 infants in the collocated NPICU/SCN, 15 
infants underwent screening for HRV, Eight infants 
were tested for HRV in the NPICU; 3 were positive 
(37.5%). Two infants had respiratory tract signs at 
the time of screening and one of them had a positive 
PCR for HRV. Of the 6 infants who had no signs of 
respiratory disease at the time of screening, 2 had 
positive PCR for HRV. Seven infants were tested in 
SCN and 1 was positive (14.3%). Three of these 
infants had signs of respiratory disease with 1 having 
a positive PCR for HRV. No children without signs 
of respiratory disease tested positive in the SCN. All 
infants with positive HRV PCR were managed with 




In another study, viral infections in patients with 
severe pneumonia requiring intensive care unit 
admission were performed in Seoul, Republic of 
Korea. From a total of 
198
 patients, 104 patients were 
tested for respiratory viruses by BAL fluid RT-PCR. 
The results shown that 72 patients (36.4%) had a viral 




In 2016, Reese et al. studied Evidence of nosocomial 
transmission of human rhinovirus in a neonatal 
intensive care unit. All visitors are screened by the 
patient’s nurse for signs of illness and asked to leave if 
they are ill. Respiratory symptoms were seen in 2 
infants. Respiratory viral testing and routine bacterial 
cultures were undertaken. The results show that 2 




The influenza virus is an epidemic infectious agent 
that belongs to the Orthomyxoviridae
13
. This family 
includes the influenza viruses A, B, C and D. They are 
pleomorphic viruses, with 7–8 single strand RNA, 
segments assembled with proteins to form a helical 
nucleocapsid. It has an envelope with two types of 
long glycoprotein spikes: one type with 
haemagglutinin activity (HA) and one type with 
neuraminidase activity (NA).  Type A viruses can 
infect and transmit across a broad host range (humans, 
mammals and birds), whereas types B and C do not 
appear to be capable of animal-to-animal or animal-to-
human transmission. Type A is the cause of global 
pandemics, whereas types B and C tend to produce 
more localized outbreaks and milder forms
14
. Severe 
acute respiratory viral infections, including influenza, 
are the principle causes of global morbidity and 
mortality. influenza infects approximately 10%-20% 
of the world’s population, annually
15
. Therefore, 
H1N1 and H3N2 are known as the seasonal influenza 
A virus subtypes
16
. Influenza remains an important 
epidemic viral infection. Influenza virus is the most 
common causative agent for severe respiratory viral 
infections in the intensive care unit (ICU), and 
frequently encountered viruses that usually cause mild 
disease
17
. Medical and neonatal ICUs, transplant units, 
chronic care wards, and nursing homes are at 
increased risk for nosocomial outbreaks of influenza, 
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which are characterized by abrupt onset and rapid 
spread. In April 2009, a new swine-origin H1N1 
influenza A virus was detected in Mexico, which was 
called pandemic H1N1 (pH1N1). In the intensive 
care units (ICUs), patients with influenza A (H1N1) 
pdm09 virus infection continue to be a seasonal 
problem, and experience a high mortality rate
18
. 
In 2009, Tabarsi et al. assayed death factors 
associated in intensive care unit admission due to 
pandemic 2009 influenza A (H1N1) infection. 
Samples including nasopharyngeal aspirates/swabs 
and endotracheal/bronchoscopic aspirates from 46 
hospitalized patients were admitted to the ICU, 20 
(43%) were admitted to the ICU and 7 (15%) died. 
The mean age of patients was 36.9 ± 12.92 years 
(range: 15–66, median: 32) and only one patient was 
over 65 years old. The male-to-female ratio was 1.3:1 
(26:20). Out the seven patients (15.2%) were 
cigarette smokers and 10 (21.7%) were drug abusers. 
H1N1 infection was confirmed by real-time reverse 
transcriptase polymerase chain reaction (rRT-PCR)
19
. 
In 2012, choi et al. studied the prevalence of viral 
infections in patients with severe pneumonia 
requiring intensive care unit admission using 
bronchoalveolar lavage (BAL) samples from 198 
patients (64 with community acquired pneumonia 
(CAP) and 134 with healthcare-associated 
pneumonia (HCAP)). The RT-PCR results showed 




In 2010, Hashemian et al. performed secondary 
infection and clinical aspects after pandemic swine–
origin influenza a (H1N1) admission in an Iranian 
critical care unite. The patient's throat discharge swab 
was cultured and evaluated with RT-PCR. Of 46 
patients hospitalized with confirmed diagnosis of 




Pérez-Carrasco et al. studied influenza infection in 
the intensive care unit.  From 163 patients, influenza 
infection was detected in 41 patients, and influenza A 
viruses were mainly responsible. Only five patients 






Human parainfluenza virus 
(HPIV) 
Acute respiratory tract infections (ARTIs) in 
childhood major cause of morbidity and mortality, 
with pneumonia being the leading cause of death 
among children between one and five years old
21, 22
. 
The human parainfluenza viruses are single-stranded 
and first discovered in 1950
23-25
. HPIVs account for a 
wide range of clinical reflections including colds, 
croup, bronchiolitis, and pneumonia
5
. Seasonal HPIV 
virus epidemics result in a significant burden of 
disease in children and account for 40% of pediatric 
hospitalizations for lower respiratory tract illnesses 
(LRTIs) and 75% of croup cases
26, 27
. 
In 2013, Sahar Essa et al. performed the potential 
influence of human parainfluenza viruses detected 
during hospitalization among critically ill patients in 
Kuwait, 2013-15. Of 1510 patients admitted to ICU 
(37.5%) and PICU (62.5%) with viral infections. A 
total of 39 (2.6%) patients were found to have 
confirmed PIV infections, with 21 (1.4%) in ICU and 
18 (1.2%) in PICU. The most frequently isolated PIV 
type was type 3 (28, 71.8%) followed by type 1 (9, 
23.1%). The least frequently isolated PIV type was 
type 4 (2, 5.1%), and type 2 was not detected. Samples 




In 2012, Choi et al. studied the viral infections in 
intensive care unit hospital in Seoul, Republic of 
Korea. From 198 patients, 72 patients (36.4%) had a 
viral infection and after detection by reverse-
transcription polymerase chain reaction (RT-PCR), the 
rate of parainfluenza virus was (20.8%)
8
. 
Retrospective study from January 2003 through 
December 2009 was carried out on influenza and 
parainfluenza associated pediatric ICU Morbidity. 
Every child in the PICU with a laboratory-confirmed 
influenza or parainfluenza infection was included. A 
total of 17 parainfluenza admissions were identified 
over the 7-year period. Parainfluenza type 3 (n=9) was 
the commonest subtype of parainfluenza infection. 
The results illustrates the important of parainfluenza 
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Human Respiratory Syncytial 
Virus (HRSV) 
Human Respiratory Syncytial Virus (HRSV) belongs 
to the family paramyxoviridae of  RNA viruses and 
has ssRNA genome 
14
. This virus is divided into two 
major antigenic groups A and B on the basis of the G 
protein variability
29
. It has envelope that contains a 
fusion protein that causes host cells to form 
multinucleated giant cells (syncytia)
14
. 
Human respiratory syncytial virus is a major cause of 
acute lower respiratory infection (ALRI) in young 
children; it also affects adults and the elderly people 
and immunocompromised patients. RSV infection 
manifests symptoms ranging from sinusitis and otitis 
media to bronchiolitis and pneumonia
30
. But general 
symptoms include fever, headache, myalgia, 
sneezing, sore throat, dry cough, rhinorrhea, 
bronchitis and otalgia, but the infection can spread to 
the lower respiratory tract of the risk groups 
mentioned above, which subsequently leads to severe 
bronchiolitis and pneumonia
29
. HRSV can cause 




Approximately 0.5% to 2.0% of all children are 
hospitalized with lower respiratory tract disease, of 
which 50% to 90% have bronchiolitis and 5% to 
40% have pneumonia
32
. 90% of children are infected 
with RSV during the first 2 years of life and up to 




Antonio Piralla et al worked on respiratory patients 
admitted to 26 intensive care units in seven 
consecutive winter-spring seasons from 2009 to 2016 
in Northern Italy. During the study period, 414 (266 
males and 148 females) patients were hospitalized in 
26 ICUs with severe respiratory distress. Respiratory 
samples were tested with a panel of laboratory-
developed real-time RT-PCR or real-time PCR able 
to detect the viruses: hRSV types A and B. Overall, 
results for  hRSV showed 13/226 or 5.8%
35
. 
Caroline Breese Hall et al. performed a study about 
RSV-associated hospitalizations among children less 
than 24 months of age. from 2000 to 2005 they 
studied on 2149 patients and they found 559 positive 
RSV cases by RT-PCR
36
. 
Leung et al. worked on epidemiology and risk factors 
for RSV infections requiring pediatric intensive care 
admission in Hong Kong children from 2009 to 2011. 
Respiratory samples were detected by direct 
immunofluorescence and/or viral culture. A total of 
118 (2.4%) PICU admissions were identified among 
4,912 RSV-positive pediatric cases in eight hospitals
37
. 
In 2014, Faghihloo et al. performed a study to 
determine genotype circulation pattern of both group 
of A and B of HRSV strains in Iran. From 485 
children <2years of age who were negative for 
influenza viruses, showed for the presence of HRSV in 
this research. HRSV was detected in 94 (19.38%) of 
the samples using nested RT-PCR. Group A viruses 
were isolated during each year, while group B viruses 
were isolated during 2009 and 2013
38
. And in the same 
study revealed that multiple genotypes of subgroup A 
co-circulated during the season 2007–2008 in Iran
39
.  
In another investigation, Faghihloo et al studied on 
genetic diversity in the G protein gene of HRSV 
among Iranian children less than 5 years with 
acute respiratory symptoms in 2011. A total of 107 
throat swabs were tested by RT-PCR. Of the 
107 samples, 24 (22.42%) were positive for HRSV, of 
which 16 (66.6%) belonged to subgroup A and 8 
(33.4%) to subgroup B. Phylogenetic analysis showed 
that subgroup A strains fell in two genotypes GA1 and 
GA2, whereas subgroup B strains clustered in 
genotype BA
40. 
Herpes simplex viruses (HSV) 
Herpesviridae includes a large family of double-
stranded DNA viruses that infect both animals and 
humans. Eight herpesviruses are known to infect 
humans: herpes simplex virus type-1 and 2 (HSV1, 
HSV2), varicella zoster virus (VZV), human 
cytomegalovirus (HCMV), Epstein-Barr virus (EBV), 
human herpesvirus 6 type-A and B (HHV6), human 




Humans are the only species known to be infected 
with two distinct herpes simplex viruses: HSV-1 and 
HSV-2. Human herpes simplex viruses are ubiquitous, 
with over two-thirds of the human population infected 
by at least one virus
43
. HSV-1 and HSV-2 establish 
latency in different neuronal subtypes (A5+ and 
KH10+) in murine trigeminal ganglia, results which  
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Table 1: Virus detection in ICU. 
Authors Date Patients Diagnostic 
Method(s) 
Detected Viruses in ICU 
Adenovirus 
 
RSV HSV1,2 CMV EBV Influenza Parainfluenza Rhinovirus 










_ _ _ _    
Ganime 









_ _ _ _    
Dingyu 




15 Real-Time 15 (100%) _ _ _ _    
Ersoy et al. 2102 24 PCR 14 
(58.3%) 











      
Caroline 




2149 RT-PCR _ 559 
(26%) 















2014 560 qPCR _ _ 76 
(14.1%) 
_ _ _   
Lepiller Q 
et al. 
2015 1556 PCR _ _ 185 
(11.8%) 




 560  _ _    _   
Lepiller Q 
et al. 
 1556 PCR _ _    _   







_ _ 19 (38%) _ _ _ _ _ 
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Ali A et al. 2018 83 qPCR _ _ 2 (2.4%) _  _ _ _ 
Coisel et 
al. 
2012 93 PCR _ _ _ 22 
(23.6
%) 
_ _ _ _ 
Heininger 
et al. 
2011 86 PCR _ _ _ 35 
(40%) 




2013 135 Nested 
PCR 
_ _ _ 2 
(1.48
%) 
_ _ _ _ 
Osawa R 
et al. 
2016 100 PCR _ _ _ 20 
(20%) 
_ _ _ _ 
David S.Y 




544 q-PCR _ _ _ 271 
(68%) 
_ _ _ _ 
Amanati A 
et al. 
2017 44 PCR _ _ _ _ 6 
(13.6
%) 
_ _ _ 
Tabarsi et 
al. 
2009 46 RT-PCR _ _ _ _ _ 20 
(43.4%) 
_ _ 
choi et al. 2012 72 RT-PCR _ _ _ _ _ 12 
(16.7%) 
15 (20.8%) 17 (23.6%) 
Hashemian 
et al. 





2013 1510 RT-PCR _ _ _ _ _ _ 39 (2.6%) _ 
AB Reid et 
al. 
2010 21 PCR _ _ _ _ _ _ _ 6 (28.5%) 
Reese S et 
al. 
2016 32 PCR _ _ _ _ _ _ _ 2 (6.25%) 
connect with restricted productive infection in these 
neurons in vitro
44
. HSV-1 is associated mainly with 
infectious of the mouth, pharynx, face, eye, CNS and 
HSV2 is associated principally with infectious of the 
anogenital region, although both serotypes may 
infect any area
45
. HSV infections in the ICU often 
involve the respiratory (pneumonia) or the central 
nervous system (encephalitis, meningitis, myelitis) 
and can cause significant morbidity and mortality 
especially in immunocompromised patients
2
.  
Walton et al. studied on reactivation of multiple 
viruses in patients with sepsis. A total of 560 septic 
patients were analyzed by quantitative PCR. 
Cumulative HSV DNA detection rates in blood were 
14.1% among other viruses. Patients who had HSV in 
blood had increased risk of developing opportunistic 
bacterial infections which was independent of length-
of-stay. For CMV and HSV, the number of ICU days 
was roughly doubled in patients who were viral 
positive versus viral negative
46
. 
Lepiller et al. performed a study to determine 
the clinical relevance of herpes simplex 
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virus viremia in ICU patients. 1556 blood samples 
obtained for HSV PCR analysis in ICU patients over 
4 years. HSV DNA was detected in 11.8% of 
samples. The mortality rate in HSV-
viremic patients was not significantly increased 
compared to the overall mortality rate in the ICU. 
Only patients with high HSV viral loads tended to 
have a higher, though non-significant, death rate. Our 
results suggest HSV viremia is common in 
ICU patients, potentially preferred by 




In another investigation by Pica et al. studied on 
clinical features and outcome of hospitalized patients 
with HSV-1 DNA in the lower respiratory tract 49 
patients of University Hospital Tor Vergata, Rome, 
Italy, from May 2013 to June 2014, were analysed 
for presence or absence of HSV-1 DNA. 19 
individuals were positive. These results recommend 
that detection of HSV-1 DNA in BAL fluid 
specimens is a marker of disease severity and poor 
outcome. More prospective studies are necessary to 
deepen the HSV-1 DNA detection in the lower 
respiratory tract of hospitalized patients
48
. 
Ali A et al. performed a study in 2018 in IRAN to 
determine Prevalence of HSV in 140 
Bronchoalveolar Lavage samples (BAL) of 83 
critically ill children undergoing mechanical 
ventilation at a PICU. Samples were analyzed by 




Epstein–Barr virus (EBV) 
The Epstein–Barr virus (EBV), also called human 
herpes virus 4 (HHV-4), is one of eight known 
human herpes virus types in the herpes family. And it 
is latent in at least 90%–95% of people, which is the 
highest rate for herpes virus
50
. EBV infection may 
suppression of patient immune system in several 
ways, like influence the proper host response to other 
pathogens and may lead to a bad outcome for 
critically ill patients. Detection of EBV in lower 
respiratory tract (LRT) and serum samples have been 
reported in the ICU population
51,52
. 
In 2017, Amanati et al. performed prevalence of 
human herpes viruses in bronchoalveolar lavage of 
critically ill children undergoing mechanical 
ventilation a pediatric Intensive Care Unit. Out of 83 
patients, 44 cases were male (53%) and (47%) were 
female. The average age of patient was 29 months. 
Overall, 19 patients were positive for HHVs. Among 
them the rate of  EBV-PCR in 6 patients were 




Cytomegalovirus is known as an important cause of 
viral intrauterine infection and disease in 
immunocompromised patients
53
. Although nearly all 
CMV infections remain latent and asymptomatic, 
numerous studies have found that systemic viral 
reactivation is common in immunocompetent critically 
ill adults. Some studies have demonstrated an 
association between CMV infection and increased 
mortality rates and prolonged intensive care unit and 
hospital length of stay
54
. 
Cytomegalovirus (CMV) is a member of the 
herpesviridae family. It has an envelope with 




More than two decades ago, Domart and colleagues 
were the first to indicate a pathogenetic role for 
Cytomegalovirus in non-canonically 
immunosuppressed patients. In a cohort of 115 
consecutive adult patients with mediastinitis after 
cardiac surgery, CMV shedding in urine, as 
determined by viral culture, was documented in 25% 
of patients of whom 79% had viremia
56
. study 
performed by Kalil and Florescu showed that the 
diagnosis rate of CMV infection increased 
significantly (from 1 to 21%) when patients who spent 
five or more days in the ICU
57.
 
with review of studies indicating the clinical 
manifestations of severe CMV disease in 
immunocompromised ICU patients found that the 
gastrointestinal tract (hepatitis, gastroenteritis, 
duodenitis, enteritis, colitis, proctitis) is to be the most 
common, followed by central nervous system 
(encephalitis, myelitis, encephalomyelitis, meningitis, 
and meningioradiculopathy), and hematological 
system (hemolytic anemia, thrombocytopenia, 
disseminated intravascular coagulation, and 
pancytopenia)
58-61
. Papazian et al. studied patients 
presenting ARDS and their open-lung biopsies to 
report that pneumonia is a well-known clinical 
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manifestation of CMV disease in 
immunocompromised patients
62
. A study performed 
by Ong et al. showed that immunocompetent patients 
with ARDS and found a CMV reactivation incidence 
of 27%, which was associated with significant 
increase in ICU mortality
63.
 
Osawa et al. showed that CMV reactivation was 
associated with fewer ICU- and ventilator-free days, 
however overall mortality was not affected. Patients 
already in the ICU at the onset of sepsis had higher 
risk of CMV reactivation
64.
 
Coisel et al. studied patients mechanically ventilated 
who are seropositive for CMV and found serious 
increased mortality in CMV-positive group; in 
addition, the diagnostic yield of BAL CMV PCR was 
73% in comparison with the detection of CMV 
antigenemia which was 46%
65
. 
Heininger et al. studied patients admitted with severe 
sepsis of whom 31% developed ICU acquired 
pneumonia and have shown lightly different 
diagnostic yield of tracheal aspirate CMV PCR of 70 
versus 62% using blood CMV PCR
66
. As in adult 
studies, CMV replication in blood is apparently to be 
the best measure of uncontrolled systemic viral 
infection in critically ill children. Although CMV in 
BAL fluid may simply represent shedding, high viral 
loads are predictive of CMV pneumonitis in 
transplant recipients and, perhaps, in critically ill 
children. Thus, pediatric ICU studies should 
incorporate CMV testing of BAL fluid
67-69
 . 
Narvaez et al. worked on a study to determine the 
incidence of congenital CMV infection and the 
frequency of postnatal infection in a 
neonatal intensive care unit (NICU). They collected 
Urine samples of 135 infants who were admitted to 
the NICU during a 6-month period to detect CMV 
and they used nested PCR assay. A breast milk 
sample was obtained to determine viral excretion. 
CMV was diagnosed in two infants (1.48%). Post-
natal infection was documented in four of 36 (11.1%) 
infants. Therefore, CMV  excretion in breast milk is 
frequent and is associated to congenital and postnatal 
infection
70. 
Human Adenoviruses (HAdVs) 
Since first isolation from adenoid tissue over 60 
years ago human adenoviruses (HAdVs) (adénos, 
gland) have contributed many challenges in clinical 
settings
71
. HAdVs are non-enveloped, double-stranded 
DNA viruses, pervasive in the environment. HAdV 
pneumonia mostly is limited to newborns, 
immunocompromised patients, and military camp 
populations. Adenoviruses cause mild infections 
including the upper or lower respiratory tract, 
gastrointestinal (GI) tract, or conjunctiva. Rare 
demonstrations of AdV infections include 
hemorrhagic cystitis, hepatitis, hemorrhagic colitis, 
pancreatitis, nephritis, and encephalitis
72
. 
The 57 identified types of  HAdVs have been 
classified into 7 species, A to G, on the basis of their 
serological, biochemical and genetic criteria
73
. HAdV-
3 of species B is among the most common types 
implicated in endemic and epidemic HAdV infections 
in children and adults in the world
74-78
. 
 Over the last few years of HAdV-3 has become the 
main agent of acute respiratory infection worldwide 




Cassir et al. described the first outbreak of severe 
pneumonia caused by human adenovirus type 1, which 
included immunocompetent patients in an ICU of 
France, and occurred between September and 
October 2012. Seven successive patients were 
diagnosed by HAdV specific real-time PCR with a 
positive bronchoalveolar lavage. Their findings 
submitted that HAdV-1 could be considered as 
possible cause of severe pneumonia even in 
immunocompetent patients with potential to cause 
outbreak in ICU
82
.    
Ganime AC et al. studied on viability and distribution 
of a hAdv on fomites in an Intensive Care Unit of a 
private hospital in Rio de Janeiro, Brazil. In this study 
141 samples were collected and screened by 
quantitative PCR (qPCR) using TaqMan System. 
Among them 63 samples (44.7%) were positive. The 
viability was indicated by integrated cell 
culture/nested-PCR in 5 out of 10 samples. Nucleotide 
sequencing confirmed all samples as HAdV and 
characterized one of them as specie B, serotype 3 
(HAdV-3). The results determined the risk of 
nosocomial transmission via contaminated fomites
83
. 
In another study Dingyu et al. 2012-2014 in Northern 
China, 15 immunocompetent patients who had severe 
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community-acquired pneumonia (CAP) were 
evaluated for Adv infection. A total 15 cases were 
confirmed with HAdV as the only pathogen of 
pneumonia. And the HAdV-55 sub-type play an 
important role among viral pneumonia pathogens in 
hospitalized immunocompetent adults. Two patients 
with HAdV positive samples were excluded due to 




Ersoy et al. described an outbreak of adenovirus 
conjunctivitis, which occurred between 15 January 
and 25 Februaryat a neonatal intensive care unit of a 
university hospital in Turkey. Adenovirus type 8 was 




Viral infections are 5 to 10 times more likely in 
ICU. Tthis review real tht these infections in the 
ICU often involve the respiratory or the central 
nervous system and include different types of 
viruses such as Human rhinoviruses (HRV), 
Influenza virus, Human parainfluenza virus 
(HPIV), Human Respiratory Syncytial Virus 
(HRSV) (RNA viruses) and Herpes simplex 
viruses (HSV), Epstein–Barr virus (EBV), 
Cytomegalovirus (CMV) and Human Adenoviruses 
(HAdVs) (DNA viruses).  
Conclusion 
Due to the significant outbreak of viruses in the ICU 
and the presence of effective treatments against some 
viruses, knowing the important viruses in this area 
and rapid diagnosing and treatment can be important. 
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